Daxor Announces Schnitzler Cardiovascular Consultants of San Antonio Acquires Blood Volume Analyzer BVA-100.NEW YORK -- Daxor Corporation (AMEX AMEX See: American Stock Exchange :DXR DXR Danbury Municipal Airport, Danbury CT (airport code) DXR Data Extraction and Recording DXR X-Director DXR Dynamic Extended Resolution ), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Schnitzler Cardiovascular Consultants of San Antonio, TX. Dr. Robert Schnitzler, Cardiovascular Consultants' Medical Director, said, "Daxor's Blood Volume Analyzer has proven to provide a significant advantage over other methods of determining a patient's clinical volume status. Knowing a patient's volume status is particularly critical in the management of heart failure, especially when different treatment options have to be considered in patients who are anemic, volume overloaded, volume depleted, or any combination of these factors." Dr. Schnitzler, a recognized pioneer in cardiology and a leading authority in the field of electrophysiology, was the first cardiologist in Texas to introduce Blood Volume Analysis to his heart failure patients at Southwest Texas Methodist Hospital of San Antonio. Since its introduction within cardiology, blood volume services have been extended to Southwest Texas Methodist's Transplant Hospital. Dr. Schnitzler stated that, "Based upon my clinical experience with the BVA-100 at Southwest Texas Methodist Hospital, it became apparent that patients within an outpatient practice would greatly benefit from a blood volume analysis to guide their particular therapeutic treatment." Along with Cardiovascular Consultants' Victoria Paparelli, MSN, Clinical Cardiology, Dr. Schnitzler recently presented at the 2005 Heart Failure Society of America, "A Word Salad in the Treatment of CHF CHF In currencies, this is the abbreviation for the Swiss Franc. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. : BVA, ICG ICG indocyanine green. , BNP BNP B-type natriuretic peptide, brain natriuretic peptide Physiology A 32-residue peptide hormone produced predominantly in the ventricles, secreted in response to fluid overload–eg, CHF. See Atrial natriuretic peptide. ," in which determining clinical volume status was assessed by various methods. In this study, Blood Volume Analysis offered superiority in the clinical assessment of the status of congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. . Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. Among nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a trial basis are The Mayo Clinic, The Cleveland Clinic and New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the Medical Center. The BVA-100 measures blood volume to within a 98% accuracy. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com. Dr. Schnitzler has no personal or financial obligations to the Daxor Corporation. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion